Back to ACAD
State of Alaska, Department of Revenue → ACAD
State of Alaska, Department of Revenue ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
14
Latest value
$511K
Q3 2026
Peak value
$1.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $220K |
| Q3 2025 | $1.3M |
| Q4 2025 | $275K |
| Q4 2025 | $1.7M |
| Q4 2025 | $677K |
| Q1 2026 | $230K |
| Q1 2026 | $1.4M |
| Q1 2026 | $565K |
| Q2 2026 | $261K |
| Q2 2026 | $1.1M |
| Q2 2026 | $642K |
| Q3 2026 | $439K |
| Q3 2026 | $164K |
| Q3 2026 | $511K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $511K | 25.4K | — | — |
| Q3 2026 | $164K | 8.2K | — | — |
| Q3 2026 | $439K | 21.8K | — | — |
| Q2 2026 | $642K | 25.4K | — | — |
| Q2 2026 | $1.1M | 41.7K | — | — |
| Q2 2026 | $261K | 10.3K | — | — |
| Q1 2026 | $565K | 25.4K | — | — |
| Q1 2026 | $1.4M | 61.8K | — | — |
| Q1 2026 | $230K | 10.3K | — | — |
| Q4 2025 | $677K | 25.4K | — | — |
| Q4 2025 | $1.7M | 64.0K | — | — |
| Q4 2025 | $275K | 10.3K | — | — |
| Q3 2025 | $1.3M | 62.8K | — | — |
| Q3 2025 | $220K | 10.3K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M